Henrik Oestergaard,Ida Hilden,Heidi Lindgreen Holmberg,Kasper Lamberth,Jes Thorn Clausen
申请号：
US13822952
公开号：
US20130266576A1
申请日:
2011.09.15
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to therapeutic FVIII antibodies. In particular, the present invention relates to FVIII antibodies having the ability to prolong the circulatory half life of FVIII. The present invention furthermore relates to use of such antibodies in treatment and prophylaxis of haemophilia A.
